Table 8 Analysis of factors associated with improved overall quality of life after hepatic surgery of FNH
From: The value of liver resection for focal nodular hyperplasia: resection yes or no?
Variables | Odds ratio (95 % CI) | p value |
|---|---|---|
Abdominal pain | ||
Moderate to extreme | 3.6 (1.1–11.4) | 0.024* |
Tenderness | ||
Moderate to extreme | 3.5 (1.1–10.5) | 0.03* |
Nausea | ||
Moderate to extreme | 2.5 (0.1–0.7) | 0.1 |
Decreased appetite | ||
Moderate to extreme | 6.3 (1.2–31.5) | 0.025* |
Fatigue | ||
Moderate to extreme | 3.5 (1.0–11.8) | 0.04* |
Type of surgery | ||
Laparascopic approach | 5.8 (1.1–31.1) | 0.03* |
Minor resection | 0.9 (0.2–3.2) | 0.9 |
Complications | ||
No complications | 2.6 (0.5–14.4) | 0.2 |
Age <40 years | 1.4 (0.4–4.4) | 0.5 |
Female gender | 0.5 (0.1–3.1) | 0.45 |
Tumor size >50 mm | 1.8 (0.6–5.3) | 0.2 |
BMI <25 (kg/m2) | 1.7 (0.6–5.1) | 0.29 |
Hospital stay <16 days | 1.1 (0.3–3.2) | 0.9 |
Unilobular tumor distribution | 2.4 (0.5–10.3) | 0.2 |
Classical FNH | 0.4 (0.1–1.4) | 0.12 |
Symptoms >9 months | 4.7 (1.3–16.4) | 0.01* |
Uncertainty of malignancy | 3.5 (0.6–18.3) | 0.1 |
Fear of complications from liver disease | 1.8 (0.5–7.0) | 0.3 |